Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nucleolar RNA SNORD27 is a noncoding RNA of the box C/D class found in the nucleolus, characterized by conserved C (UGAUGA) and D (CUGA) box motifs[4]. Its canonical function is to guide the site-specific 2′-O-methylation of adenosine 27 in 18S rRNA by directing the methyltransferase fibrillarin[1][2]. Beyond its role in rRNA biogenesis, SNORD27 is also found in a fibrillarin-free nuclear fraction, where it associates with spliceosomal complexes and regulates the alternative splicing of specific pre-mRNAs (notably E2F7, a cell cycle regulator, as well as MAP4K3, ZBTB37, FER, and ABCA8)[1][2][5]. This splicing regulation is achieved by base pairing to pre-mRNA sequences near splice sites, sometimes suppressing the inclusion of cryptic or weak alternative exons[1][2]. Thus, SNORD27 links ribosome biogenesis and RNA splicing, and its dysregulation has implications in cancer and cell proliferation[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA SNORD27 (SNORD27).